Chirurgische Studien - im follow up, multizentrisch:
PORTAS-3
DRKS00004900
Multizentrische, randomisierte, kontrollierte Studie (RCT) zum Vergleich der Komplikationsraten der offenen vs. geschlossenen Implantationsstrategie von Portkathetern (TIVAP) bei onkologischen Patienten
| Indikation | Onkologische Patienten, die zur Chemotherapie oder parenteralen Ernährung einen dauerhaften venösen Zugang benötigen |
| Primärer Endpunkt | Pneumo/Hämatothorax |
| Studienleiter | PD Dr. med. Phillip Knebel, Heidelberg |
| Patienten-information | vom 24.07.2014 |
| Publikationen | Protokoll |
ESPAC 5F
ESPAC-5F. Four arm, prospective, multicentre, randomised feasibility trial of immediate surgery compared with neoadjuvant chemotherapies and neoadjuvant chemoradiotherapy for patients with borderline resectable adenocarcinoma of the pancreas.
| Indikation | Borderline resectable mass in the pancreatic head as defined by CT criteria (histologically proven) |
| Ziel der Studie | Recruitment rate and Resection rate. Resection rate will be measured using the total number of patients in the arm as baseline and, secondly, using the number of patients having explorative surgery. R1 and R0 resection margins will be included in the resection rate but not R2 resection. R1 will be defined as per the Royal College of Pathologists (RCP) report on Standards and datasets for reporting cancers |
| Studienleiter | Prof. Paula Ghaneh MBChB MD FRCS |
| Patienten-Information | - |